LIQUIDIA CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
LIQUIDIA CORPORATION (LQDA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.46M shares, a 67.39% decline from fiscal 2022.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.49M shares, a 121.81% increase from fiscal 2021.
- LIQUIDIA CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 2.02M shares, a 41.86% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-12 | 0.00 shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-12 | 0.00 shares 10-Q · filed 2025-11-03 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 0.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2025-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-08 | 0.00 shares derived: sum of 3 quarters · filed 2025-05-08 | 7.50K shares 8-K · filed 2025-05-08 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 7.50K shares 10-Q · filed 2024-11-13 | 48.00K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 7.50K shares 10-Q · filed 2024-08-07 | 48.00K shares derived: sum of 3 quarters · filed 2024-08-07 | 97.60K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 7.50K shares 10-Q · filed 2024-05-13 | 48.00K shares derived: sum of 2 quarters · filed 2024-05-13 | 97.60K shares derived: sum of 3 quarters · filed 2024-05-13 | 327.20K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 40.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 90.10K shares derived: sum of 2 quarters · filed 2024-03-13 | 319.70K shares derived: sum of 3 quarters · filed 2024-03-13 | 1.46M shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 49.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 279.20K shares derived: sum of 2 quarters · filed 2023-11-07 | 1.42M shares 10-Q · filed 2023-11-07 | 1.43M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 229.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 1.37M shares 10-Q · filed 2023-08-10 | 1.38M shares derived: sum of 3 quarters · filed 2023-08-10 | 2.25M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 1.14M shares 10-Q · filed 2023-05-08 | 1.15M shares derived: sum of 2 quarters · filed 2023-05-08 | 2.02M shares derived: sum of 3 quarters · filed 2023-05-08 | 3.18M shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 4.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 877.60K shares derived: sum of 2 quarters · filed 2023-03-20 | 2.03M shares derived: sum of 3 quarters · filed 2023-03-20 | 4.49M shares 10-K · filed 2023-03-20 |
| 2022-09-30 | 873.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 2.03M shares derived: sum of 2 quarters · filed 2022-11-08 | 4.49M shares 10-Q · filed 2022-11-08 | 4.51M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 1.15M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 3.61M shares 10-Q · filed 2022-08-11 | 3.63M shares derived: sum of 3 quarters · filed 2022-08-11 | 4.35M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 2.46M shares 10-Q · filed 2022-05-12 | 2.48M shares derived: sum of 2 quarters · filed 2022-05-12 | 3.20M shares derived: sum of 3 quarters · filed 2022-05-12 | 3.32M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 23.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 741.30K shares derived: sum of 2 quarters · filed 2022-03-17 | 861.03K shares derived: sum of 3 quarters · filed 2022-03-17 | 2.02M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 718.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 837.83K shares derived: sum of 2 quarters · filed 2021-11-03 | 2.00M shares 10-Q · filed 2021-11-03 | |
| 2021-06-30 | 119.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 1.28M shares 10-Q · filed 2021-08-10 | ||
| 2021-03-31 | 1.16M shares 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | 3.48M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |